Home/Filings/4/0001127602-21-018165
4//SEC Filing

HENDERSON LORI M. 4

Accession 0001127602-21-018165

CIK 0001682852other

Filed

May 26, 8:00 PM ET

Accepted

May 27, 4:04 PM ET

Size

8.4 KB

Accession

0001127602-21-018165

Insider Transaction Report

Form 4
Period: 2021-05-25
HENDERSON LORI M
General Counsel and Secretary
Transactions
  • Exercise/Conversion

    Common Stock

    2021-05-25$14.85/sh+6,600$98,0107,501 total
  • Sale

    Common Stock

    2021-05-25$166.58/sh6,600$1,099,428901 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2021-05-256,600334,952 total
    Exercise: $14.85Exp: 2028-06-26Common Stock (6,600 underlying)
Footnotes (2)
  • [F1]The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on December 23, 2020.
  • [F2]25% of this option will vest and become exercisable on April 9, 2019 with the remainder vesting in 12 equal quarterly installments thereafter.

Issuer

Moderna, Inc.

CIK 0001682852

Entity typeother

Related Parties

1
  • filerCIK 0001221127

Filing Metadata

Form type
4
Filed
May 26, 8:00 PM ET
Accepted
May 27, 4:04 PM ET
Size
8.4 KB